Zobrazeno 1 - 4
of 4
pro vyhledávání: '"David M Vardanyan"'
Autor:
Anna N Balandina, Ilya I Serebriyskiy, Alexander V Poletaev, Dmitry M Polokhov, Marina A Gracheva, Ekaterina M Koltsova, David M Vardanyan, Irina A Taranenko, Alexey Yu Krylov, Evdokiya S Urnova, Kirill V Lobastov, Artem V Chernyakov, Elena M Shulutko, Andrey P Momot, Alexander M Shulutko, Fazoil I Ataullakhanov
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0199900 (2018)
BACKGROUND:Heparin therapy and prophylaxis may be accompanied by bleeding and thrombotic complications due to individual responses to treatment. Dosage control based on standard laboratory assays poorly reflects the effect of the therapy. The aim of
Externí odkaz:
https://doaj.org/article/9a03bc72c5854baba31ca00d958bb354
Autor:
Ekaterina M. Koltsova, Anna D. Kuprash, Natalya M. Dashkevich, David M. Vardanyan, Artem V. Chernyakov, Maria A. Kumskova, Sukesh C. Nair, Alok Srivastava, Fazoil I. Ataullakhanov, Mikhail A. Panteleev, Anna N. Balandina
Publikováno v:
Platelets, Vol 32, Iss 8, Pp 1031-1037 (2021)
In this work, we present a new method—Thrombodynamics-4D—for the assessment of both plasma and platelet contributions to clotting. Thrombodynamics-4D potentially allows for the determination of plasma or platelet disorders and the effects of vari
Externí odkaz:
https://doaj.org/article/6ddc4c2ece6043279d6c28817a28557f
Autor:
Mikhail A. Panteleev, Fazoil I. Ataullakhanov, Anna D. Kuprash, Natalya M. Dashkevich, E. M. Koltsova, Maria A. Kumskova, Anna N. Balandina, Sukesh C. Nair, Artem V. Chernyakov, Alok Srivastava, David M. Vardanyan
Publikováno v:
Platelets. 32(8)
In this work, we present a new method-Thrombodynamics-4D-for the assessment of both plasma and platelet contributions to clotting. Thrombodynamics-4D potentially allows for the determination of plasma or platelet disorders and the effects of various
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3786a012db508e4b9baeaa0d1b568021
https://pubmed.ncbi.nlm.nih.gov/32967497
https://pubmed.ncbi.nlm.nih.gov/32967497
Autor:
A P Momot, Alexander M. Shulutko, Irina Alekseevna Taranenko, Fazoil I. Ataullakhanov, Anna N. Balandina, Elena M. Shulutko, David M. Vardanyan, Ilya I. Serebriyskiy, Kirill Lobastov, E S Urnova, Alexander V Poletaev, Alexey Yu. Krylov, Marina A. Gracheva, E. M. Koltsova, Artem V. Chernyakov, Dmitry M. Polokhov
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 6, p e0199900 (2018)
PLoS ONE, Vol 13, Iss 6, p e0199900 (2018)
Background Heparin therapy and prophylaxis may be accompanied by bleeding and thrombotic complications due to individual responses to treatment. Dosage control based on standard laboratory assays poorly reflects the effect of the therapy. The aim of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51b4ad43e9a7a53b8fd34fad9acc647a
https://pubmed.ncbi.nlm.nih.gov/29953528
https://pubmed.ncbi.nlm.nih.gov/29953528